ENTBF Financials: Entheon Biomedical Corp. AI Analysis



Financials

ENTBF Financial

Entheon Biomedical Corp.

0%

$0

At close: May 22, 16:00:00 GMT-4

0%

$0

Post-market: May 22, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is ENTHEON BIOMEDICAL CORP.?

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-05-03. The firm is interested in treating addiction and substance-use disorders.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	250,735	60,940	65,627	64,009	60,159	54,878
Revenue Growth (YoY)	13%	11%	19%	22%	1%	0%
Cost of Revenue	241,319	58,442	63,230	61,690	57,957	52,755
Gross Profit	9,416	2,498	2,397	2,319	2,202	2,123
Selling, General & Admin	5,991	1,542	1,504	1,461	1,484	1,315
Research & Development	--	--	--	--	--	--
Operating Expenses	6,346	1,637	1,588	1,548	1,573	1,392
Other Non Operating Income (Expenses)	35	-16	11	10	30	9
Pretax Income	2,004	392	630	598	384	665
Income Tax Expense	456	12	159	144	141	157
Net Income	1,555	399	467	450	239	506
Net Income Growth	0%	-21%	17%	8%	1%	96%
Shares Outstanding (Diluted)	236	236	237	239	239	241
Shares Change (YoY)	-2%	-2%	-2%	-2%	-3%	-2%
EPS (Diluted)	6.58	1.69	1.97	1.88	1	2.09
EPS Growth	2%	-19%	20%	11%	4%	100%
Free Cash Flow	4,392	1,677	555	865	1,295	2,791
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	3.75%	4.09%	3.65%	3.62%	3.66%	3.86%
Operating Margin	1.22%	1.41%	1.23%	1.2%	1.04%	1.33%
Profit Margin	0.62%	0.65%	0.71%	0.7%	0.39%	0.92%
Free Cash Flow Margin	1.75%	2.75%	0.84%	1.35%	2.15%	5.08%
EBITDA	3,994	1,109	1,043	1,004	838	938
EBITDA Margin	1.59%	1.81%	1.58%	1.56%	1.39%	1.7%
D&A For EBITDA	924	248	234	233	209	207
EBIT	3,070	861	809	771	629	731
EBIT Margin	1.22%	1.41%	1.23%	1.2%	1.04%	1.33%
Effective Tax Rate	22.75%	3.06%	25.23%	24.08%	36.71%	23.6%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenue

250,735

60,940

65,627

64,009

60,159

54,878

Revenue Growth (YoY)

13%

11%

19%

22%

Cost of Revenue

241,319

58,442

63,230

61,690

57,957

52,755

Gross Profit

9,416

2,498

2,397

2,319

2,202

2,123

Selling, General & Admin

5,991

1,542

1,504

1,461

1,484

1,315

Research & Development

Operating Expenses

6,346

1,637

1,588

1,548

1,573

1,392

Other Non Operating Income (Expenses)

-16

Pretax Income

2,004

392

630

598

384

665

Income Tax Expense

456

159

144

141

157

Net Income

1,555

399

467

450

239

506

Net Income Growth

-21%

17%

96%

Shares Outstanding (Diluted)

236

237

239

241

Shares Change (YoY)

-2%

-3%

-2%

EPS (Diluted)

6.58

1.69

1.97

1.88

2.09

EPS Growth

-19%

20%

11%

100%

Free Cash Flow

4,392

1,677

555

865

1,295

2,791

Free Cash Flow Per Share

Gross Margin

3.75%

4.09%

3.65%

3.62%

3.66%

3.86%

Operating Margin

1.22%

1.41%

1.23%

1.2%

1.04%

1.33%

Profit Margin

0.62%

0.65%

0.71%

0.7%

0.39%

0.92%

Free Cash Flow Margin

1.75%

2.75%

0.84%

1.35%

2.15%

5.08%

EBITDA

3,994

1,109

1,043

1,004

838

938

EBITDA Margin

1.59%

1.81%

1.58%

1.56%

1.39%

1.7%

D&A For EBITDA

924

248

234

233

209

207

EBIT

3,070

861

809

771

629

731

EBIT Margin

1.22%

1.41%

1.23%

1.2%

1.04%

1.33%

Effective Tax Rate

22.75%

3.06%

25.23%

24.08%

36.71%

23.6%

Follow-Up Questions

What are Entheon Biomedical Corp.'s key financial statements?



According to the latest financial statement (Form-10K), Cardinal Health Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for ENTBF?



Cardinal Health Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Entheon Biomedical Corp.'s revenue broken down by segment or geography?



Cardinal Health Inc largest revenue segment is Pharmaceutical and Specialty Solutions, at a revenue of 204,644,000,000 in the most earnings release.For geography, United States is the primary market for Cardinal Health Inc, at a revenue of 220,993,000,000.

Is Entheon Biomedical Corp. profitable?



no, according to the latest financial statements, Cardinal Health Inc has a net loss of $0

Does Entheon Biomedical Corp. have any liabilities?



no, Cardinal Health Inc has liability of 0

How many outstanding shares for Entheon Biomedical Corp.?



Cardinal Health Inc has a total outstanding shares of 0

Entheon Biomedical Corp. (ENTBF) Financial

ENTBF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is ENTHEON BIOMEDICAL CORP.?

Entheon Biomedical Corp. (ENTBF) Financial

ENTBF Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is ENTHEON BIOMEDICAL CORP.?

ENTBF Income

Follow-Up Questions

What are Entheon Biomedical Corp.'s key financial statements?

What are the key financial ratios for ENTBF?

How is Entheon Biomedical Corp.'s revenue broken down by segment or geography?

Is Entheon Biomedical Corp. profitable?

Does Entheon Biomedical Corp. have any liabilities?

How many outstanding shares for Entheon Biomedical Corp.?